Resultados de la búsqueda 11-20 of 14735 for Zolpidem

  1. Mayo Clinic Health Letter: puntos destacados de la edición de febrero de 2014

    Estos medicamentos, tales como el zolpidem (Ambien y demás), la eszopiclona (Lunesta) o el zaleplón (Sonata), no deben usarse por más de cuatro u ocho ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the ...

  3. Mayo Clinic Physician Update - June 2026

    Page 1.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  6. Alimentación mediterránea para la salud del corazón. - Mayo Clinic

    clbemp-bu;="3ccm999od,Column--e="32x3hdf25.707 13.707L4.t.)ochevrmp-b//ta-cmplayer="{&quwida14 -atp://ta-c.wida14 f/spau/espuwida14 -atp://ta-c.wida14 ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic ...